Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS TPM TPM max in non-specific ABCB1 ABC20, CD243, CLCS, GP170, MDR1, P-gp, PGY1 ENSG00000085563 ATP-binding cassette, sub-family B (MDR/TAP), member 1 7 87503633-87713323 Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB001716, HPA002199 Approved Approved Nucleoplasm
Focal adhesion sites
Cytosol Tissue enhanced 0 adrenal gland: 138.6;small intestine: 83.9 kidney: 37.0 AC007163.2 ENSG00000280298 2 200682822-200683196 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level HPA042797 Uncertain Tissue enhanced 0 adrenal gland: 2.7;spleen: 2.4;testis: 2.2 small intestine: 0.7 AC069063.1 ENSG00000279131 3 115113420-115114210 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Tissue enhanced 0 adrenal gland: 3.1 thyroid gland: 2.0 ADAMTSL2 KIAA0605 ENSG00000197859 ADAMTS-like 2 9 133532164-133575519 Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA045634, HPA053812 Approved Approved Nucleoplasm
Vesicles Tissue enhanced 0 adrenal gland: 29.2 kidney: 11.1 ADGRA1 GPR123, KIAA1828 ENSG00000197177 Adhesion G protein-coupled receptor A1 10 133070929-133131675 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA042773 Approved Tissue enhanced 0 adrenal gland: 4.9;cerebral cortex: 22.5 fallopian tube: 3.1 AGRP Agrt, ART, ASIP2 ENSG00000159723 Agouti related neuropeptide 16 67482571-67483813 Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA041017 Uncertain Tissue enhanced 0 adrenal gland: 5.8;epididymis: 24.7 lung: 3.0 AMHR2 MISR2, MISRII ENSG00000135409 Anti-Mullerian hormone receptor, type II 12 53423855-53431534 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA060228, HPA069636 Approved Vesicles Tissue enhanced 0 adrenal gland: 32.2;ovary: 40.8 testis: 10.1 AVPR1A AVPR1 ENSG00000166148 Arginine vasopressin receptor 1A 12 63142759-63150942 FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 adrenal gland: 78.3 adipose tissue: 19.9 BAIAP3 BAP3, KIAA0734 ENSG00000007516 BAI1-associated protein 3 16 1333601-1349441 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA015627 Uncertain Tissue enhanced 0 adrenal gland: 25.1;cerebral cortex: 25.2;fallopian tube: 41.9 testis: 13.8 C11orf96 AG2 ENSG00000187479 Chromosome 11 open reading frame 96 11 43925342-43944338 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA038843 Uncertain Approved Nucleus
Focal adhesion sites
Cytosol Tissue enhanced 0 adrenal gland: 164.1 adipose tissue: 126.9 C1orf233 ENSG00000228594 Chromosome 1 open reading frame 233 1 1598012-1600096 Predicted membrane proteins Evidence at protein level Evidence at transcript level No evidence Evidence at protein level Tissue enhanced 0 adrenal gland: 12.8 cerebral cortex: 9.5 C2CD2 C21orf25, C21orf258, DKFZP586F0422, TMEM24L ENSG00000157617 C2 calcium-dependent domain containing 2 21 41885112-41953890 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA030922, HPA030924 Approved Approved Nucleoplasm Tissue enhanced 0 adrenal gland: 110.3 spleen: 46.8 C2orf66 UNQ6411 ENSG00000187944 Chromosome 2 open reading frame 66 2 196805002-196810276 Predicted secreted proteins Evidence at transcript level Evidence at transcript level No evidence HPA020869 Uncertain Tissue enhanced 0 adipose tissue: 2.8;adrenal gland: 1.7;testis: 1.7 skin: 1.1 C4B C4B1, C4B3, C4F, CH, CO4, CPAMD3 ENSG00000224389 Complement component 4B (Chido blood group) 6 32014762-32035418 Blood group antigen proteins, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA046356, HPA048287, HPA050103 Approved Tissue enhanced 0 adrenal gland: 59.8;liver: 65.6 kidney: 18.4 C7 ENSG00000112936 Complement component 7 5 40909252-40982939 Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA001465 Approved Tissue enhanced 0 adrenal gland: 1120.3 placenta: 710.8 CABP7 MGC57793 ENSG00000100314 Calcium binding protein 7 22 29720084-29731839 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA016439 Uncertain Tissue enhanced 0 adrenal gland: 2.5;cerebral cortex: 3.4 small intestine: 1.4 CAMK2N2 CaM-KIIN ENSG00000163888 Calcium/calmodulin-dependent protein kinase II inhibitor 2 3 184259213-184261463 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA050835 Supported Nucleus
Centrosome Tissue enhanced 0 adrenal gland: 12.3;cerebral cortex: 40.5 pancreas: 5.6 CBARP BARP, C19orf26, DOS, MGC40084 ENSG00000099625 Calcium channel, voltage-dependent, beta subunit associated regulatory protein 19 1228287-1238027 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA012777 Uncertain Approved Nucleoplasm Tissue enhanced 0 adrenal gland: 2.4;cerebral cortex: 7.0 testis: 1.1 CBLN4 CBLNL1, dJ885A10.1 ENSG00000054803 Cerebellin 4 precursor 20 55997440-56005472 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA056335, HPA074497 Supported Uncertain Endoplasmic reticulum Tissue enhanced 0 adrenal gland: 24.7;cerebral cortex: 15.7;epididymis: 11.0 fallopian tube: 6.7 CBWD7 ENSG00000215126 COBW domain containing 7 9 41131306-41199261 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level No evidence HPA042759, HPA042813 Approved Approved Plasma membrane Tissue enhanced 0 adrenal gland: 4.9 breast: 2.8 CDH18 CDH14, EY-CADHERIN ENSG00000145526 Cadherin 18, type 2 5 19472951-20575873 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA014416 Uncertain Tissue enhanced 0 adrenal gland: 5.9;cerebral cortex: 19.1 testis: 3.2 CELA1 ELA1 ENSG00000139610 Chymotrypsin-like elastase family, member 1 12 51328443-51346679 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 adrenal gland: 2.5;pancreas: 1.3 lymph node: 0.9 CHRNA7 ENSG00000175344 Cholinergic receptor, nicotinic, alpha 7 (neuronal) 15 32030488-32172521 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA029422, CAB033624 Supported Tissue enhanced 0 adrenal gland: 6.0;small intestine: 6.0 stomach: 3.6 CHRNB4 ENSG00000117971 Cholinergic receptor, nicotinic, beta 4 (neuronal) 15 78624119-78727754 FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 adrenal gland: 3.2;testis: 5.3 appendix: 0.9 CLRN1 RP61, USH3, USH3A ENSG00000163646 Clarin 1 3 150926163-150972999 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA054636 Uncertain Tissue enhanced 0 adrenal gland: 6.8;duodenum: 1.6 testis: 0.8 COL22A1 ENSG00000169436 Collagen, type XXII, alpha 1 8 138588235-138914006 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA024830 Approved Supported Endoplasmic reticulum
Vesicles Tissue enhanced 0 adrenal gland: 9.8 prostate: 4.8 CRYBA2 ENSG00000163499 Crystallin, beta A2 2 218990189-218993421 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 adrenal gland: 4.6;stomach: 4.6 small intestine: 3.1 CSDC2 PIPPin ENSG00000172346 Cold shock domain containing C2, RNA binding 22 41560763-41577741 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA003073, HPA076549 Uncertain Approved Nucleoplasm
Cytosol Tissue enhanced 0 adrenal gland: 62.8;ovary: 72.1 heart muscle: 45.8 CYP2W1 FLJ20359, MGC34287 ENSG00000073067 Cytochrome P450, family 2, subfamily W, polypeptide 1 7 983199-989640 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA012753 Uncertain Tissue enhanced 0 adrenal gland: 5.6;duodenum: 6.3;skin: 9.7 placenta: 1.4 DFNB31 CIP98, PDZD7B, USH2D, WHRN ENSG00000095397 Deafness, autosomal recessive 31 9 114402080-114505450 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002480, CAB033194 Uncertain Tissue enhanced 0 adrenal gland: 73.4 testis: 44.5 DLX1 ENSG00000144355 Distal-less homeobox 1 2 172084740-172089677 Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA035666, HPA045884 Approved Approved Nucleus
Vesicles
Cell Junctions Tissue enhanced 0 adrenal gland: 1.6;cerebral cortex: 5.0 prostate: 0.7 DNAJC12 JDP1 ENSG00000108176 DnaJ (Hsp40) homolog, subfamily C, member 12 10 67796665-67838166 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA036289, HPA058161 Approved Approved Nucleus
Cytosol Tissue enhanced 0 adrenal gland: 58.0 breast: 38.7 EPHA8 EEK, Hek3 ENSG00000070886 EPH receptor A8 1 22563564-22603594 Cancer-related genes, Enzymes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB009660, HPA031433 Uncertain Tissue enhanced 0 adrenal gland: 4.9;spleen: 2.7;testis: 1.9 cerebral cortex: 1.3 EVX1 ENSG00000106038 Even-skipped homeobox 1 7 27242700-27250493 Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA055132 Approved Nucleoplasm Tissue enhanced 0 adrenal gland: 3.7;prostate: 4.6;seminal vesicle: 4.3 testis: 1.5 FAM131C C1orf117, FLJ36766 ENSG00000185519 Family with sequence similarity 131, member C 1 16057769-16073632 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA031046 Uncertain Approved Nucleoli
Intermediate filaments
Cytosol Tissue enhanced 0 adrenal gland: 3.3;cerebral cortex: 4.8;kidney: 3.8 heart muscle: 1.2 FAM150B ENSG00000189292 Family with sequence similarity 150, member B 2 279558-288851 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 adrenal gland: 258.3 ovary: 82.8 FAM163A C1orf76, MGC16664 ENSG00000143340 Family with sequence similarity 163, member A 1 179743163-179816198 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA010778 Uncertain Tissue enhanced 0 adrenal gland: 7.7;testis: 9.7 gallbladder: 1.8 FAM43B FLJ44952 ENSG00000183114 Family with sequence similarity 43, member B 1 20552439-20555010 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA050813 Approved Approved Cytosol Tissue enhanced 0 adrenal gland: 10.4 epididymis: 3.4 FEV Pet-1 ENSG00000163497 FEV (ETS oncogene family) 2 218981087-218985657 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level HPA067679 Supported Approved Nuclear speckles Tissue enhanced 0 adrenal gland: 2.1;duodenum: 3.0;stomach: 2.4 prostate: 1.9 FGF11 FHF3, FLJ16061, MGC102953, MGC45269 ENSG00000161958 Fibroblast growth factor 11 17 7438273-7444937 Predicted intracellular proteins, RAS pathway related proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA066605 Approved Centrosome Tissue enhanced 0 adrenal gland: 34.8;skin: 27.6 cerebral cortex: 20.7 FGF12 FGF12B, FHF1 ENSG00000114279 Fibroblast growth factor 12 3 192139395-192767764 Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA071557 Approved Nucleoplasm
Cytosol Tissue enhanced 0 adrenal gland: 46.9;cerebral cortex: 52.5;heart muscle: 94.9 spleen: 16.4 FIBCD1 FLJ14810 ENSG00000130720 Fibrinogen C domain containing 1 9 130902438-130939286 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA053898, HPA055353 Uncertain Supported Cell Junctions Tissue enhanced 0 adrenal gland: 4.7;parathyroid gland: 8.5;testis: 5.3 cerebral cortex: 2.5 FNDC4 FLJ22362, FRCP1 ENSG00000115226 Fibronectin type III domain containing 4 2 27491883-27495245 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA051804, HPA063581 Uncertain Approved Nucleoplasm
Aggresome
Cytosol Tissue enhanced 0 adrenal gland: 72.9 cerebral cortex: 36.0 GALR1 GALNR, GALNR1 ENSG00000166573 Galanin receptor 1 18 77250549-77277896 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 adrenal gland: 2.1;cerebral cortex: 1.7 testis: 0.5 GNG8 ENSG00000167414 Guanine nucleotide binding protein (G protein), gamma 8 19 46634076-46634685 Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 adrenal gland: 29.5 cerebral cortex: 10.3 GRAMD1B KIAA1201 ENSG00000023171 GRAM domain containing 1B 11 123454398-123627774 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008557 Approved Approved Nucleus
Nucleoli
Intermediate filaments Tissue enhanced 0 adrenal gland: 87.8 cerebral cortex: 39.0 GRIK1 GluK1, GLUR5 ENSG00000171189 Glutamate receptor, ionotropic, kainate 1 21 29536933-29940033 FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014623 Uncertain Tissue enhanced 0 adrenal gland: 16.8;cerebral cortex: 9.1 prostate: 3.9 GSTA1 ENSG00000243955 Glutathione S-transferase alpha 1 6 52791664-52803910 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004342, HPA048934, HPA053817 Supported Supported Cytosol Tissue enhanced 0 adrenal gland: 1142.9;kidney: 1300.7;liver: 1750.1 small intestine: 1023.4 HIST2H3PS2 p06 ENSG00000203818 Histone cluster 2, H3, pseudogene 2 1 143905556-143905966 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA042570 Supported Tissue enhanced 0 adrenal gland: 8.5;spleen: 7.9 ovary: 5.8 HIST3H2A MGC3165 ENSG00000181218 Histone cluster 3, H2a 1 228456979-228457873 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA041189 Supported Tissue enhanced 0 adrenal gland: 22.8 cerebral cortex: 10.7 HOXA5 HOX1, HOX1C ENSG00000106004 Homeobox A5 7 27141052-27143668 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029319 Uncertain Tissue enhanced 0 adrenal gland: 110.5;epididymis: 59.1 fallopian tube: 43.5 HSPA1B HSP70-2 ENSG00000204388 Heat shock 70kDa protein 1B 6 31827735-31830255 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level CAB008640, HPA052504 Approved Uncertain Nucleoplasm
Vesicles Tissue enhanced 0 adrenal gland: 34.3 urinary bladder: 15.0 IFITM10 ENSG00000244242 Interferon induced transmembrane protein 10 11 1732410-1750591 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 adrenal gland: 12.7;cerebral cortex: 12.0 seminal vesicle: 4.0 IL23R IL-23R ENSG00000162594 Interleukin 23 receptor 1 67166400-67259979 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA056427 Uncertain Tissue enhanced 0 adrenal gland: 2.1;testis: 2.2 rectum: 0.9 INHA ENSG00000123999 Inhibin, alpha 2 219569162-219575713 Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000047, HPA019141 Supported Approved Vesicles Tissue enhanced 0 adrenal gland: 51.8;ovary: 37.9;testis: 106.5 placenta: 14.8 INSM1 IA-1, IA1 ENSG00000173404 Insulinoma-associated 1 20 20368121-20370949 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 adrenal gland: 9.4;stomach: 5.7 duodenum: 3.1 INSRR IRR ENSG00000027644 Insulin receptor-related receptor 1 156840063-156859018 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA025285 Uncertain Tissue enhanced 0 adrenal gland: 1.8;kidney: 1.4;testis: 2.2 prostate: 0.6 IZUMO1R Folbp3, FOLR4, JUNO ENSG00000183560 IZUMO1 receptor, JUNO 11 94305593-94307721 Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 adrenal gland: 1.0 lymph node: 0.7 KCNA4 HK1, HPCN2, KCNA4L, Kv1.4 ENSG00000182255 Potassium channel, voltage gated shaker related subfamily A, member 4 11 30009741-30017023 FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB001977, HPA016422 Approved Tissue enhanced 0 adrenal gland: 7.9;cerebral cortex: 4.3 heart muscle: 1.2 KCNG3 Kv6.3 ENSG00000171126 Potassium channel, voltage gated modifier subfamily G, member 3 2 42442017-42494097 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA041625 Approved Cytoplasmic bodies Tissue enhanced 0 adrenal gland: 1.2;cerebral cortex: 1.3;testis: 1.1 endometrium: 0.4 KCNH5 eag2, H-EAG2, Kv10.2 ENSG00000140015 Potassium channel, voltage gated eag related subfamily H, member 5 14 62699454-63102037 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA030487 Uncertain Uncertain Microtubules
Mitotic spindle Tissue enhanced 0 adrenal gland: 1.4;cerebral cortex: 3.6 testis: 0.7 KCNJ5 CIR, GIRK4, KATP1, Kir3.4, LQT13 ENSG00000120457 Potassium channel, inwardly rectifying subfamily J, member 5 11 128891356-128921035 Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014722, HPA017353, CAB022569 Supported Tissue enhanced 0 adrenal gland: 85.2 spleen: 19.1 KCNK2 K2p2.1, TREK-1 ENSG00000082482 Potassium channel, two pore domain subfamily K, member 2 1 215005775-215237093 FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA056054 Uncertain Approved Mitochondria
Cytosol Tissue enhanced 0 adrenal gland: 75.5 thyroid gland: 17.3 KCNK3 K2p3.1, TASK, TASK-1 ENSG00000171303 Potassium channel, two pore domain subfamily K, member 3 2 26692690-26733420 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 adrenal gland: 112.3;placenta: 35.5 lung: 19.9 KCNN2 hSK2, KCa2.2 ENSG00000080709 Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 2 5 114360945-114496500 Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA038221 Uncertain Uncertain Nucleoplasm
Cytosol Tissue enhanced 0 adrenal gland: 27.4;prostate: 18.5 liver: 15.9 KCNQ1 JLNS1, KCNA8, KCNA9, Kv7.1, KVLQT1, LQT, LQT1 ENSG00000053918 Potassium channel, voltage gated KQT-like subfamily Q, member 1 11 2444684-2849109 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018656, HPA048553 Supported Tissue enhanced 0 adrenal gland: 134.2;thyroid gland: 102.8 seminal vesicle: 60.3 KLHL4 DKELCHL, KHL4, KIAA1687 ENSG00000102271 Kelch-like family member 4 X 87517749-87670050 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029192 Approved Supported Microtubules
Microtubule organizing center Tissue enhanced 0 adrenal gland: 37.4 testis: 15.5 L1CAM CD171, HSAS, HSAS1, MASA, MIC5, S10, SPG1 ENSG00000198910 L1 cell adhesion molecule X 153861514-153909223 CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA005830, CAB010896 Approved Approved Nucleoplasm
Plasma membrane Tissue enhanced 0 adrenal gland: 36.2;cerebral cortex: 67.1 seminal vesicle: 12.7 LINGO4 LRRN6D ENSG00000213171 Leucine rich repeat and Ig domain containing 4 1 151800264-151806154 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA060781 Uncertain Tissue enhanced 0 adrenal gland: 2.3;skeletal muscle: 4.1 fallopian tube: 1.0 LRRN3 FIGLER5, FLJ11129, NLRR3 ENSG00000173114 Leucine rich repeat neuronal 3 7 111091006-111125454 Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA043820, HPA046792 Uncertain Approved Nucleus
Cytosol Tissue enhanced 0 adrenal gland: 30.9;cerebral cortex: 31.2;testis: 29.0;thyroid gland: 33.4 lung: 11.6 MAB21L1 CAGR1 ENSG00000180660 Mab-21-like 1 (C. elegans) 13 35474182-35477209 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA049324, HPA059864 Approved Nucleoplasm Tissue enhanced 0 adrenal gland: 5.5;breast: 5.6 adipose tissue: 2.5 MAMSTR FLJ36070, MASTR ENSG00000176909 MEF2 activating motif and SAP domain containing transcriptional regulator 19 48712742-48719721 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA049765 Approved Nuclear speckles Tissue enhanced 0 adrenal gland: 21.5;skeletal muscle: 31.4 fallopian tube: 10.4 MAPK4 Erk3-related, Erk4, PRKM4 ENSG00000141639 Mitogen-activated protein kinase 4 18 50560078-50731824 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 adrenal gland: 29.9;cerebral cortex: 33.5;parathyroid gland: 59.0 seminal vesicle: 13.7 MCOLN3 FLJ11006, TRP-ML3, TRPML3 ENSG00000055732 Mucolipin 3 1 85018082-85048499 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA018106, HPA062137 Approved Approved Nucleoli
Cytosol Tissue enhanced 0 adrenal gland: 57.9;parathyroid gland: 42.1 epididymis: 17.3 MYO7A DFNA11, DFNB2, NSRD2, USH1B ENSG00000137474 Myosin VIIA 11 77128264-77215239 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA028918, CAB034059 Uncertain Supported Cytosol Tissue enhanced 0 adrenal gland: 26.9;placenta: 20.7 testis: 17.2 NCBP2L ENSG00000170935 Nuclear cap binding protein subunit 2-like X 107777733-107794682 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level No evidence HPA010664 Uncertain Tissue enhanced 0 adrenal gland: 1.9;fallopian tube: 1.6;testis: 3.9 ovary: 1.1 NDRG4 KIAA1180, SMAP-8 ENSG00000103034 NDRG family member 4 16 58462846-58513628 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015313, HPA017587 Supported Uncertain Nucleus
Cytosol Tissue enhanced 0 adrenal gland: 147.3;cerebral cortex: 421.4 heart muscle: 140.8 NEUROD4 ATH-3, Atoh3, bHLHa4, MATH-3 ENSG00000123307 Neuronal differentiation 4 12 55019945-55030014 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at transcript level HPA015545 Supported Tissue enhanced 0 adrenal gland: 2.3;testis: 1.0 cerebral cortex: 0.4 NGEF ARHGEF27 ENSG00000066248 Neuronal guanine nucleotide exchange factor 2 232878686-233013272 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA008160 Approved Uncertain Plasma membrane
Cytosol Tissue enhanced 0 adrenal gland: 66.8;cerebral cortex: 151.9 duodenum: 44.0 NKAIN1 FAM77C, FLJ12650 ENSG00000084628 Na+/K+ transporting ATPase interacting 1 1 31179745-31239554 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA006873 Uncertain Tissue enhanced 0 adrenal gland: 13.9;cerebral cortex: 13.1;skeletal muscle: 7.4 epididymis: 4.4 NPTX2 ENSG00000106236 Neuronal pentraxin II 7 98617297-98629868 Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB020801, HPA049799 Supported Tissue enhanced 0 adrenal gland: 33.6;cerebral cortex: 80.5;testis: 44.4 cervix: 12.0 NR4A2 HZF-3, NOT, NURR1, RNR1, TINUR ENSG00000153234 Nuclear receptor subfamily 4, group A, member 2 2 156324432-156342348 Cancer-related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level HPA000543, CAB010481 Uncertain Supported Nuclear speckles Tissue enhanced 0 adrenal gland: 175.5 ovary: 95.2 NR4A3 CHN, CSMF, MINOR, NOR1 ENSG00000119508 Nuclear receptor subfamily 4, group A, member 3 9 99821855-99866891 Cancer-related genes, Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level HPA043360 Uncertain Tissue enhanced 0 adrenal gland: 89.5 urinary bladder: 43.5 PABPN1L ePABP2 ENSG00000205022 Poly(A) binding protein, nuclear 1-like (cytoplasmic) 16 88863333-88866660 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA043415 Uncertain Tissue enhanced 0 adrenal gland: 1.0 bone marrow: 0.5 PCDH15 CDHR15, DFNB23, USH1F ENSG00000150275 Protocadherin-related 15 10 53802771-55627942 Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 adrenal gland: 25.1;cerebral cortex: 12.3 kidney: 8.1 PCSK2 NEC2, PC2, SPC2 ENSG00000125851 Proprotein convertase subtilisin/kexin type 2 20 17226107-17484578 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA049627 Approved Approved Vesicles Tissue enhanced 0 adrenal gland: 37.7;cerebral cortex: 31.8 skin: 16.5 PDGFD IEGF, MSTP036, SCDGF-B ENSG00000170962 Platelet derived growth factor D 11 103907186-104164379 Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA046183, HPA066271 Approved Approved Golgi apparatus
Vesicles Tissue enhanced 0 adrenal gland: 141.1 ovary: 96.4 PIRT ENSG00000233670 Phosphoinositide-interacting regulator of transient receptor potential channels 17 10822475-10838445 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA042337 Uncertain Uncertain Plasma membrane
Cytosol Tissue enhanced 0 adrenal gland: 3.1;cerebral cortex: 2.7;rectum: 2.7 colon: 2.1 PLCXD3 ENSG00000182836 Phosphatidylinositol-specific phospholipase C, X domain containing 3 5 41306954-41510628 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA046849 Uncertain Approved Golgi apparatus Tissue enhanced 0 adrenal gland: 16.8;heart muscle: 21.1;ovary: 28.3 cerebral cortex: 8.3 PRPH NEF4, PRPH1 ENSG00000135406 Peripherin 12 49293252-49298686 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002437, HPA039277, HPA063887 Supported Tissue enhanced 0 adrenal gland: 20.7 appendix: 11.7 QPCT GCT, QC ENSG00000115828 Glutaminyl-peptide cyclotransferase 2 37344574-37373322 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA008406 Uncertain Approved Cytosol Tissue enhanced 0 adrenal gland: 159.5;epididymis: 119.5 skin: 41.1 RAET1G ULBP5 ENSG00000203722 Retinoic acid early transcript 1G 6 149916878-149923121 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA062673 Approved Vesicles Tissue enhanced 0 adrenal gland: 8.3;esophagus: 9.6 skin: 3.4 RALYL HNRPCL3 ENSG00000184672 RALY RNA binding protein-like 8 84182787-84921844 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA055868, HPA059112 Supported Supported Nucleoplasm Tissue enhanced 0 adrenal gland: 26.2;cerebral cortex: 49.3;kidney: 19.6 gallbladder: 8.2 RAPGEF4 cAMP-GEFII, CGEF2 ENSG00000091428 Rap guanine nucleotide exchange factor (GEF) 4 2 172735274-173052893 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004388, HPA028968 Approved Approved Focal adhesion sites Tissue enhanced 0 adrenal gland: 53.6;cerebral cortex: 119.5 liver: 18.2 RARRES2 HP10433, TIG2 ENSG00000106538 Retinoic acid receptor responder (tazarotene induced) 2 7 150338317-150341674 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA049359 Uncertain Cytosol Tissue enhanced 0 adrenal gland: 1529.4 parathyroid gland: 904.5 RBKS DKFZp686G13268, RBSK ENSG00000171174 Ribokinase 2 27781364-27891098 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019725, HPA028285 Supported Approved Cytosol Tissue enhanced 0 adrenal gland: 34.9 kidney: 19.4 RFX6 dJ955L16.1, MGC33442, RFXDC1 ENSG00000185002 Regulatory factor X, 6 6 116877212-116932163 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level HPA037696, HPA037697 Approved Supported Nucleus
Nucleoli Tissue enhanced 0 adrenal gland: 6.0;stomach: 7.3 duodenum: 2.3 RGN RC, SMP30 ENSG00000130988 Regucalcin X 47078355-47093314 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029102, HPA029103 Supported Approved Nucleus Tissue enhanced 0 adrenal gland: 203.8;liver: 196.1 kidney: 56.6 RIMS2 KIAA0751, OBOE, RAB3IP3, RIM2 ENSG00000176406 Regulating synaptic membrane exocytosis 2 8 103500748-104256094 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046538, HPA066498 Supported Approved Cytosol Tissue enhanced 0 adrenal gland: 68.1;cerebral cortex: 45.4 cervix: 11.5 RP4-583P15.15 ENSG00000273154 20 63708864-63739103 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Tissue enhanced 0 adrenal gland: 1.2;appendix: 1.1 duodenum: 0.5 RUNDC3B RPIB9, RPIP9 ENSG00000105784 RUN domain containing 3B 7 87627548-87832296 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA056968, HPA057155 Uncertain Tissue enhanced 0 adrenal gland: 9.7 cerebral cortex: 7.2 SCD5 ACOD4, FADS4, FLJ21032, HSCD5, SCD4 ENSG00000145284 Stearoyl-CoA desaturase 5 4 82629539-82798857 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042380 Uncertain Tissue enhanced 0 adrenal gland: 201.7;cerebral cortex: 502.5 epididymis: 117.9 SERPINA5 PAI3, PCI, PLANH3, PROCI ENSG00000188488 Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 14 94561442-94593120 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA056919 Approved Mitochondria Tissue enhanced 0 adrenal gland: 516.7;liver: 406.5;testis: 816.1 gallbladder: 251.6 SHH HHG1, HLP3, HPE3, MCOPCB5, SMMCI, TPT, TPTPS ENSG00000164690 Sonic hedgehog 7 155799986-155812273 Disease related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 adrenal gland: 12.0;stomach: 10.7;urinary bladder: 14.0 cervix: 6.7 SHISA8 C22orf17, Orf26 ENSG00000234965 Shisa family member 8 22 41909554-41914667 Predicted membrane proteins Evidence at transcript level Evidence at transcript level No evidence HPA059173 Uncertain Tissue enhanced 0 adrenal gland: 4.4 lymph node: 1.4 SLC10A4 MGC29802 ENSG00000145248 Solute carrier family 10, member 4 4 48483343-48489196 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA028835 Uncertain Supported Tissue enhanced 0 adrenal gland: 6.2;cerebral cortex: 4.0 cervix: 1.5 SLC16A9 C10orf36, FLJ43803, MCT9 ENSG00000165449 Solute carrier family 16, member 9 10 59650761-59736002 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA049286 Approved Approved Nucleus
Cell Junctions Tissue enhanced 0 adrenal gland: 199.5;kidney: 199.2 spleen: 57.0 SLC27A6 ACSVL2, FACVL2, FATP6, VLCS-H1 ENSG00000113396 Solute carrier family 27 (fatty acid transporter), member 6 5 128538013-129033642 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA008987 Approved Approved Nuclear bodies Tissue enhanced 0 adrenal gland: 32.7;fallopian tube: 33.7 testis: 24.1 SLC35D3 FRCL1 ENSG00000182747 Solute carrier family 35, member D3 6 136922264-136925639 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA030431, HPA067497 Uncertain Approved Microtubule organizing center Tissue enhanced 0 adrenal gland: 1.2 lung: 0.6 SLC47A1 FLJ10847, MATE1 ENSG00000142494 Solute carrier family 47 (multidrug and toxin extrusion), member 1 17 19495385-19579034 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021987 Supported Tissue enhanced 0 adrenal gland: 139.0;kidney: 105.0 liver: 55.2 SLC6A2 NAT1, NET, NET1, SLC6A5 ENSG00000103546 Solute carrier family 6 (neurotransmitter transporter), member 2 16 55655604-55706192 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004057, CAB078195 Supported Supported Approved Mitochondria
Cytosol Tissue enhanced 0 adrenal gland: 29.4;placenta: 18.2;skin: 15.7 testis: 11.4 SLITRK4 DKFZp547M2010 ENSG00000179542 SLIT and NTRK-like family, member 4 X 143622790-143635777 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA000431 Approved Uncertain Microtubules Tissue enhanced 0 adrenal gland: 14.0;cerebral cortex: 12.8 cervix: 8.3 SMIM10L2A LED, LINC00086, MGC39606, NCRNA00086 ENSG00000178947 Small integral membrane protein 10 like 2A X 135421943-135428074 Predicted membrane proteins Evidence at transcript level Evidence at transcript level No evidence Tissue enhanced 0 adrenal gland: 21.9;cerebral cortex: 22.6 epididymis: 17.4 SNCG BCSG1, persyn, SR ENSG00000173267 Synuclein, gamma (breast cancer-specific protein 1) 10 86958618-86963260 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001452, HPA014404, CAB040581 Supported Approved Approved Golgi apparatus
Plasma membrane Tissue enhanced 0 adipose tissue: 174.4;adrenal gland: 199.0;urinary bladder: 190.7 seminal vesicle: 113.6 SOAT1 ACAT, SOAT, STAT ENSG00000057252 Sterol O-acyltransferase 1 1 179293714-179358680 Enzymes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009533, HPA047171 Supported Validated Endoplasmic reticulum Tissue enhanced 0 adrenal gland: 219.3 prostate: 44.0 SSTR5 ENSG00000162009 Somatostatin receptor 5 16 1078781-1080142 FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA066503 Supported Plasma membrane Tissue enhanced 0 adrenal gland: 1.2 heart muscle: 0.8 ST8SIA5 SIAT8E ENSG00000101638 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 18 46667821-46759257 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA043813, HPA046771 Approved Approved Plasma membrane
Midbody Tissue enhanced 0 adrenal gland: 5.5;cerebral cortex: 11.5 parathyroid gland: 3.4 STK32A MGC22688, YANK1 ENSG00000169302 Serine/threonine kinase 32A 5 147234963-147387852 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA040236 Uncertain Approved Centrosome Tissue enhanced 0 adrenal gland: 15.7;thyroid gland: 16.1 cerebral cortex: 7.4 SULT2A1 DHEA-ST, STD ENSG00000105398 Sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 19 47870466-47886397 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018755, HPA041487, HPA063633 Supported Supported Cytosol Tissue enhanced 0 adrenal gland: 190.8;liver: 513.8 small intestine: 93.1 SV2C ENSG00000122012 Synaptic vesicle glycoprotein 2C 5 76083172-76353939 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA040722, HPA040770 Supported Approved Nucleoplasm
Vesicles Tissue enhanced 0 adrenal gland: 1.7;cerebral cortex: 3.4 ovary: 0.6 SYT4 HsT1192, KIAA1342 ENSG00000132872 Synaptotagmin IV 18 43267878-43277650 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA010574 Approved Supported Vesicles
Plasma membrane Tissue enhanced 0 adrenal gland: 20.5;cerebral cortex: 82.7 seminal vesicle: 11.1 TBX3 TBX3-ISO, UMS, XHL ENSG00000135111 T-box 3 12 114670254-114684164 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005799 Approved Nucleoplasm
Cytosol Tissue enhanced 0 adrenal gland: 201.8 prostate: 114.3 TLX2 Enx, HOX11L1, NCX, Tlx2 ENSG00000115297 T-cell leukemia homeobox 2 2 74513463-74517147 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level HPA040969, HPA062254 Uncertain Approved Nucleoplasm Tissue enhanced 0 adrenal gland: 2.7 testis: 0.8 TMEM200C TTMA ENSG00000206432 Transmembrane protein 200C 18 5882072-5895955 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA047253, HPA050490 Uncertain Approved Microtubules Tissue enhanced 0 adrenal gland: 3.1;cerebral cortex: 3.5 salivary gland: 1.8 TMEM63C C14orf171, CSC1, DKFZp434P0111, hsCSC1 ENSG00000165548 Transmembrane protein 63C 14 77116568-77259495 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA030657 Uncertain Approved Centrosome Tissue enhanced 0 adrenal gland: 12.9;cerebral cortex: 18.6;testis: 13.8 epididymis: 5.5 TMIE DFNB6 ENSG00000181585 Transmembrane inner ear 3 46701333-46710886 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA038298 Uncertain Uncertain Vesicles
Cytosol Tissue enhanced 0 adrenal gland: 7.5;cerebral cortex: 5.3 testis: 1.7 TNXB TNXB1, TNXB2, TNXBS, XB, XBS ENSG00000168477 Tenascin XB 6 32041154-32115334 Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA070464 Approved Vesicles Tissue enhanced 0 adrenal gland: 92.0 endometrium: 18.7 TPD52L1 D53, hD53 ENSG00000111907 Tumor protein D52-like 1 6 125119049-125264407 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA027915, HPA027916 Approved Approved Plasma membrane
Cell Junctions
Cytosol Tissue enhanced 0 adrenal gland: 321.3 salivary gland: 126.8 TUBB4A beta-5, DYT4, TUBB4 ENSG00000104833 Tubulin, beta 4A class IVa 19 6494319-6502848 Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010768, HPA043640, HPA046280 Approved Validated Microtubules Tissue enhanced 0 adrenal gland: 138.8;cerebral cortex: 556.4 testis: 102.6 UCP1 SLC25A7, UCP ENSG00000109424 Uncoupling protein 1 (mitochondrial, proton carrier) 4 140559434-140568805 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 adrenal gland: 3.7 breast: 0.9 UNC80 C2orf21, FLJ33496, KIAA1843, UNC-80 ENSG00000144406 Unc-80 homolog (C. elegans) 2 209771993-209999300 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA042472 Approved Approved Vesicles Tissue enhanced 0 adrenal gland: 5.1;cerebral cortex: 15.8;testis: 5.2 gallbladder: 1.9 UTS2 PRO1068, U-II, UCN2, UII ENSG00000049247 Urotensin 2 1 7843083-7853512 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA017000 Uncertain Tissue enhanced 0 adrenal gland: 4.0 lymph node: 2.0 VEPH1 FLJ12604, KIAA1692 ENSG00000197415 Ventricular zone expressed PH domain-containing 1 3 157259742-157533619 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA026645 Uncertain Approved Nucleus
Nucleoli
Cytosol Tissue enhanced 0 adrenal gland: 26.8;kidney: 28.5;lung: 43.9 epididymis: 21.0 VSTM2A MGC33530, VSTM2 ENSG00000170419 V-set and transmembrane domain containing 2A 7 54542325-54571080 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA021404, HPA024134 Uncertain Tissue enhanced 0 adrenal gland: 12.7;cerebral cortex: 40.9;prostate: 13.4 stomach: 4.8 WDR63 DIC3, FLJ30067, NYD-SP29 ENSG00000162643 WD repeat domain 63 1 84999147-85133138 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA038526 Supported Tissue enhanced 0 adrenal gland: 28.4;fallopian tube: 22.8;testis: 33.4 parathyroid gland: 6.1 WNT11 ENSG00000085741 Wingless-type MMTV integration site family, member 11 11 76186325-76210736 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA050101, HPA063569 Uncertain Approved Centrosome
Cytosol Tissue enhanced 0 adipose tissue: 29.6;adrenal gland: 17.5 placenta: 5.7 WNT8B ENSG00000075290 Wingless-type MMTV integration site family, member 8B 10 100463041-100483744 Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA036570 Uncertain Tissue enhanced 0 adrenal gland: 1.1;parathyroid gland: 1.5;testis: 1.6 kidney: 0.6 ZBED6CL C7orf29 ENSG00000188707 ZBED6 C-terminal like 7 150329789-150332721 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA019724, HPA055805 Approved Approved Nuclear membrane
Vesicles Tissue enhanced 0 adrenal gland: 31.9;parathyroid gland: 30.0 lymph node: 10.0